Study on the Effect of Salvia miltiorrhiza on Lowering Blood Lipid Based on Zebrafish Hyperlipidemia Model
Published: 2022-11-03
Page: 191-199
Issue: 2022 - Volume 4 [Issue 1]
Xinyu Wen
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
Tao Yuan
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
Yan Deng
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
Yue Chen
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
Hongzhi Li
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
Yi Huang *
School of Life Science and Engineering, Southwest University of Science and Technology, Mianyang, Sichuan-621010, China.
*Author to whom correspondence should be addressed.
Abstract
Objective: This study investigated the lipid-lowering effects of Salvia miltiorrhiza by constructing the high blood lipid zebrafish model.
Methods: The hyperlipidemia model was constructed using egg yolk to feed the zebrafish larval. On this basis, Zebrafish larval with hyperlipidemia were treated with different concentrations of Salvia miltiorrhiza extract. Then the light density, length, cholesterol, and triglyceride content were determined. By comparing the above data between the drug treatment group and the blank group, the hypolipidemic efficacy of Salvia miltiorrhiza was analyzed.
Results: The triglyceride (TG) and total cholesterol (TC) contents of the model groups were significantly increased comparing control group, showing that the hyperlipidemia model had been effectively established. After treatment with 0.516 μg/ml, 1.135 μg/ml, and 2.325 μg/ml of Salvia miltiorrhiza extract, the lipid reduction in the hyperlipidemia model was 27.11%, 41.58%, and 62.83%, respectively. Furthermore, the TG content was reduced by 32.07%, 53.12%, and 51.46%. The TC content was reduced by 20.29%, 29.55%, and 38.80%, respectively.The data of each group were statistically significant (P<0.01).
Conclusion: Salvia miltiorrhiza has a good hypolipidemic effect in the zebrafish hyperlipidemia model. The above data provide a basis for the further development of Salvia miltiorrhiza in the field of hypolipidemic.
Keywords: Zebrafish, Salvia miltiorrhiza, hypolipidemic
How to Cite
References
Shijun Yin, Congpeng Zhao, Guang Hu, et al. Investigation on the Metabolism of Salvianolic acid B, Tanshinone IIA, Ginsenoside Rg1 and Ginsenoside Rb1 from Danshen- Sanqi Herbal Pair in Zebrafish by Liquid Chromatography- Tandem Mass Spectrometry Analysis[J]. Clinical Complementary Medicine and Pharmacology. 2021;1(1):1-8.
Yue Chen, Yanting Wang, Juan Guo, et al. Integrated Transcriptomics and Proteomics to Reveal Regulation Mechanism and Evolution of SmWRKY61 on Tanshinone Biosynthesis in Salvia miltiorrhiza and Salvia castanea [J]. Frontiers in Plant Science. 2022; 12.
Ding M, Ye T X, Zhao G R, et al. A queous extract of Salvia miltiorrhiza attenuats increased endothelial permeability induced by tumor necrosis factora [J]. Interna- tional Immunopharmacol. 2005,5(11): 1641-1651.
Oberkersch Roxana E, Lidonnici Jacopo, Santoro Massimo M. How to Generate a Vascular-Labelled Transgenic Zebrafish Model to Study Tumor Angiogenesis and Extravasation.[J]. Methods in Molecular Biology. 2023,2572.
Larijani Bagher, Hamidpour Shayesteh Kokabi, TayanlooBeik Akram, et al. An Overview of Zebrafish Modeling Methods in Drug Discovery and Development [M]. Advances in Experimental Medicine and Biology; 2021.
Saravanan S, Pari L. Role of thymol on hyperglycemia and hyperlipidemia in high fat diet-induced type 2 diabetic C57BL / 6J mice [J]. European Journal of Pharmacology. 2015;761:279-287.
Naziri Mahdyieh, Ghafari Arezoo, Mehrabi Hoda, et al. A Mini-Review of the Anticancer Properties of Cryptotanshinone: A Quinoid Diterpene Extracted From the Root of Salvia miotiorrhiza Bunge[J]. Frontiers in Drug Discovery; 2022.
Omer Ibrahim Abdallh Omer. A Review on Zebra Fish as a Preclinical Model for Natural Drug Discovery[J]. Pharmaceutical Science and Technology. 2021;5(2):62-67
Zhou J, Xu YQ, Guo SY, et al. Rapid analysis of hypolipidemic drugs in a live zebrafish assay [J]. J Pharmacol Toxicol Methods. 2015;72:47-52.
Huang C C, Monte A, Cook J M, et al. Zebrafish heart failure models for the evaluation of chemical probes and drugs [J]. Assay and Drug Development Technologies. 2013;11(9/10):561-572.
Mhlongo Fikile, Cordero-Maldonado Maria Lorena, Crawford Alexander D, et al. Evaluation of the wound healing properties of South African medicinal plants using zebrafish and in vitro bioassays[J]. Journal of Ethnopharmacology. 2022,286:114867.